Pergolide (trade names Permax, Prascend) is an ergoline-based dopamine
receptor agonist used in some countries for the treatment of Parkinson's disease.
What is Pergolide? Pergolide (pergolide mesylate) controls the output of a
hormone called ACTH. If ACTH is not controlled, the pituitary tumor grows
Easy to read patient leaflet for pergolide mesylate. Includes indications, proper
use, special instructions, precautions, and possible side effects.
Prascend® (pergolide mesylate) is the only FDA-approved formulation of
pergolide mesylate on the market approved for use in horses. PRASCEND is the
Jun 13, 2005 ... Pergolide is a long-acting dopamine agonist approved in 1982 for the treatment
of Parkinson's Disease. It is an ergot derivative that acts on the ...
Dec 8, 2004 ... Permax (Pergolide Mesylate) is an ergot derivative dopamine receptor agonist at
both D1 and D2 receptor sites. Pergolide mesylate is ...
Consumer information about the medication PERGOLIDE - ORAL (Permax),
includes side effects, drug interactions, recommended dosages, and storage ...
Note: Pergolide in cookies is not the best option. The cookies are made of oats
and molasses which are Insulin Resistance triggers. Many Pergolide syrups have
Mar 3, 2016 ... Issued: April 20, 2012. Reissued: March 2, 2016. Dear Equine Veterinarian: In
September 2011, FDA approved PRASCEND (pergolide ...
Aug 15, 2013 ... The drug is also known and marketed by its generic name pergolide [per-go-lide].
I am Pat Clarke from F-D-A's Center for Drug Evaluation and ...